Assignee
SHANGHAI SPARK PHARMACEUTICAL CO LTD
CN·2 granted patents·5 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
7 records- 0161US2025127753A1Pharmaceutical application of dimyricetin-yl-diselenide in tumorsSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0258US2025127754A1Pharmaceutical Application of Dimyricetin-yl-diselenide in AtherosclerosisSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0349US11618741B2Method for preparing diselenide compoundSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2020·Granted Apr 4, 2023·0 cites·5 claims
- 0448US12043603B2Method for extracting and separating dihydromyricetin from rattan teaSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 23, 2024·0 cites·6 claims
- 0544US2022040142A1Pharmaceutical application for the inhibition of novel coronaviruses by myricetinSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0644US2022079913A1Dihydromyricetin with anti-alcoholic effectSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0744US2022071947A1Pharmaceutical application of dimyricetin-based diselenideSHANGHAI SPARK PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI SPARK PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →